Bird & Bird is called upon by market-leading corporations to advise on complex, business-critical regulatory and commercial matters. The team has recently supported clients in relation to key EU initiatives, including draft proposals under the EHDS, the Critical Medicines Act and the Pharma Package. The practice demonstrates strength in pharmaceutical and regulatory litigation. Practice head Marc Martens covers the full lifecycle of medicinal product and biomedical device development. Kevin Munungu brings deep expertise in EU regulatory and procurement matters, while Benedicte Mourisse advises on core life sciences regulatory issues.
Legal 500 Editorial commentary
Accolades
Client satisfaction: NPS ®
Key clients
- Polpharma Pharmaceutical Works, Neuraxpharm, Laboratorios Lesvi S.L.U.
- Ethics Committees of several Belgian Universities: Université de Mons, Université de Namur, Catholic University of Louvain, UCLouvain.
- Teva Pharma
- Sumitomo Pharma, Marines Transparency Belgium, AdHoc Clinical, Envyzant, InhaTarget Therapeutics
- IDRx, Articure, Boehringer Ingelheim, Gilead, Larima Therapeutics, CAMP4 Therapeutics, Analysis group
- Azelis Group NV
- Novo Holdings and Novo Nordisk
- STADA Arzneimittel AG
Work highlights
Representing Polpharma in the high-profile regulatory dispute over generic access to Tecfidera.
Represented several pharmaceutical companies and Belgian universities in litigation brought by GAIA seeking access to confidential Ethics Committee documents.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Leading associates
Leading associates with regular involvement in their team's key work, and recognition from peers or clients as being ones to watch.
Practice head
Marc Martens
Other key lawyers
Kevin Munungu; Benedicte Mourisse